Metal Catalysts and
Ligands
for Organic Synthesis
|
| Listed
below are the new Metal Catalysts and Ligands for Organic
Synthesis introduced in Catalog 18. For a complete listing see
the "blue section" of our catalog please email to sales@advtechind.com |
 |
Flagged
items have been introduced since Catalog 18 was printed. |
ALUMINUM |
|
13-5800 |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum
(III) chloride, 98% |
1g
5g |
13-5801 |
(1S,2S)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum
(III) chloride, 98% |
1g
5g |
CHROMIUM |
24-0850 |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]chromium
(III) chloride, 98% |
1g
5g |
24-0851 |
(1S,2S)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]chromium
(III) chloride, 98% |
1g
5g |
COBALT |
| 27-0525 |
(1R,2R)-(-)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-
butylsalicylidene)cobalt (II)
 |
1g
5g
25g
|
| 27-0526 |
(1S,2S)-(+)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-
butylsalicylidene)cobalt (II) |
1g
5g
25g |
COPPER |
|
29-6700
|
Tetrakis(acetonitrile)copper
(I) hexafluorophosphate, 98+% |
5g
25g |
Technical
Note:
- Useful catalyst for the
Ullman synthesis.

Reference:
- J. Org. Chem., 1999,
64, 2986.
|
IRON |
|
26-0200 |
(+)-1,1'-Bis((2R,4R)-2,4-diethylphosphotano)ferrocene,
min. 95% (R,R)-Et-FerroTANEÔ
Note: Sold for research purposes only. Sold
in collaboration with Chirotech. |
100mg
500mg |
26-0201 |
(-)-1,1'-Bis((2S,4S)-2,4-diethylphosphotano)ferrocene,
min. 95% (S,S)-Et-FerroTANEÔ

Note: Sold for research
purposes only. Sold in collaboration with Chirotech.
|
100mg
500mg |
26-0275 |
1,1'-Bis(di-i-propylphosphino)ferrocene,
min. 98% |
500mg
2g |
LANTHANUM |
|
57-0200 |
Di-[3-((R)-2,2'-dihydroxy-1,1'-binaphthylmethyl)]ether,
lanthanum (III) salt SCT-(R)-BINOL
 |
100mg
500mg |
57-0201 |
Di-[3-((S)-2,2'-dihydroxy-1,1'-binaphthylmethyl)]ether,
lanthanum (III) salt SCT-(S)-BINOL |
100mg
500mg |
MOLYBDENUM |
|
| 42-1212 |
2,6-Diisopropylphenylimidoneophylidene[racemic-BIPHEN]
molybdenum (VI), min. 97%
rac-SCHROCK-HOVEYDA CATALYST |
100mg
500mg
2g |
| BIPHEN=5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol |
| 42-1213 |
2,6-Diisopropylphenylimidoneophylidene[(R)-(+)-BIPHEN]
molybdenum (VI), min. 97%
(R) SCHROCK-HOVEYDA CATALYST |
100mg
500mg
2g |
| 42-1214 |
2,6-Diisopropylphenylimidoneophylidene[(S)-(-)-BIPHEN]
molybdenum (VI), min. 97%
(S) SCHROCK-HOVEYDA CATALYST |
100mg
500mg
2g |
|
|
|
NICKEL |
|
28-0500 |
Dichloro[1,1'-Bis(diphenylphosphino)ferrocene]nickel
(II) |
1g
5g |
NITROGEN |
|
07-0299 |
1,3-Bis(2,4,6-trimethylphenyl)imidazolium
chloride, min. 95%
 |
1g
5g |
| 07-0302 |
1,3-Bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium
tetrafluoroborate
 |
1g
5g |
07-0303 |
(+)-2,6-Bis[(4R)-4-phenyl-2-oxazolin-2-yl]pyridine,
98+%
 |
500mg
2g |
07-0304 |
(-)-2,6-Bis[(4S)-4-phenyl-2-oxazolin-2-yl]pyridine,
98+% |
500mg
2g |
07-0340 |
(-)-N,N'-(1R,2R)-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide),
min. 98% |
1g
5g |
07-0341 |
(+)-N,N'-(1S,2S)-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide),
min. 98%
 |
1g
5g |
07-0590 |
1,3-Bis(2,6-di-i-propylphenyl)imidazolium
chloride, min. 95% |
500mg
2g |
OXYGEN |
|
08-0600 |
(R)-(+)-3,3'-Dibromo-1,1'-bi-2-naphthol,
99%
 |
100mg
500mg |
08-0601 |
(S)-(-)-3,3'-Dibromo-1,1'-bi-2-naphthol,
99% |
100mg
500mg |
08-0605 |
(R)-(+)-6,6'-Dibromo-1,1'-bi-2-naphthol,
99%
 |
500mg
2g |
08-0606 |
(S)-(-)-6,6'-Dibromo-1,1'-bi-2-naphthol,
99% |
500mg
2g |
| 08-2045 |
racemic-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol,
99%
rac-BIPHEN H2
 |
5g
25g |
| 08-2046 |
(R)-(+)-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-
biphenyl-2,2'-diol, 99%
(R) BIPHEN H2 |
100mg
500mg
2g |
| 08-2047 |
(S)-(-)-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-
biphenyl-2,2'-diol, 99%
(S) BIPHEN H2 |
100mg
500mg
2g |
PALLADIUM |
|
46-0252 |
Bis(tri-t-butylphosphine)palladium
(O), 98% |
250mg
1g |
| 46-0290 |
trans-Di(µ-acetato)bis[o-(di-o-tolylphosphino)benzyl]
dipalladium (II), 98+%
 |
1g
5g |
PHOSPHORUS |
|
15-0145 |
2,2'-Bis(diphenylphosphino)-1,1'-biphenyl,
98% BIPHEP
 |
250mg
1g |
15-0425 |
(R)-(-)-4,12-Bis(diphenylphosphino)-[2.2]-paracyclophane,
min. 95% (R)-PHANEPHOS |
100mg
500mg |
15-0426 |
(S)-(+)-4,12-Bis(diphenylphosphino)-[2.2]-paracyclophane,
min. 95% (S)-PHANEPHOS
 |
100mg
500mg |
| 15-0380 |
Bis(2-diphenylphosphinophenyl)ether
 |
5g
25g |
15-0410 |
(+)-1,2-Bis((2R,5R)-2,5-di-i-propylphospholano)benzene,
98+%
(R,R)-i-Pr-DUPHOS |
100mg
500mg
2g |
15-0411 |
(-)-1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)benzene,
98+%
(S,S)-i-Pr-DUPHOS |
100mg
500mg
2g |
| 15-0960 |
(1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis
(2'-diphenylphosphinobenzoyl), 98%
TROST
LIGAND

Note: Sold in collaboration with Chirotech. |
100mg
500mg
2g |
| 15-0961 |
(1S,2S)-(-)-1,2-Diaminocyclohexane-N,N'-
bis (2'-diphenylphosphinobenzoyl), 98%
TROST
LIGAND
Note: Sold in collaboration with Chirotech. |
100mg
500mg
2g |
15-0963 |
(1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2-diphenylphosphino-1-naphthoyl,
min. 94% TROST
LIGAND (NAPHTHYL)
Note: Sold in collaboration with Chirotech. |
100mg
500mg
2g |
15-0964 |
(1S,2S)-(-)-1,2-Diaminocyclohexane-N,N'-bis(2-diphenylphosphino-1-naphthoyl,
min. 94% TROST
LIGAND (NAPHTHYL)

Note: Sold in collaboration with Chirotech. |
100mg
500mg
2g |
15-1043 |
racemic-2-(Di-t-butylphosphino)-1,1'-binaphthyl,
98%
 |
250mg
1g |
| 15-1045 |
2-(Di-t-butylphosphino)biphenyl,
99%
 |
500mg
2g |
| 15-1140 |
2-(Dicyclohexylphosphino)biphenyl,
98%
 |
500mg
2g |
15-1145 |
2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl,
98%
 |
500mg
2g |
15-1148 |
2-(Dicyclohexylphosphino)-2'-methylbiphenyl,
99% |
500mg
2g |
15-1242 |
9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene,
min. 98%
XANTPHOS
 |
1g
5g |
15-1745 |
2-(Diphenylphosphino)-2'-(N,N-dimethylamino)biphenyl,
98% |
500mg
2g |
| 15-1773 |
(-)-(2S,4S)-2-Diphenylphosphinomethyl-4-diphenyl
phosphino-1-t-butoxycarbonylpyrrolidine BPPM
 |
100mg
500mg |
15-1821 |
(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-(1-methylethyl)-4,5-dihydrooxazole,
98%
 |
250mg
1g |
15-1822 |
(S)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-(1-methylethyl)-4,5-dihydrooxazole,
98% |
250mg
1g |
15-5811 |
Tri-t-butylphosphine,
99% (10 wt% in hexane) |
1g
5g |
15-5812 |
Tri-t-butylphosphine,
99% (10 wt% in hexane) (Sure/SealÔ
bottle) |
5g |
| 15-7720 |
Tris(2,4-di-t-butylphenyl)phosphite,
98% |
10g
250g
1kg |
RHODIUM |
|
|
| 45-0148 |
(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene
(cyclooctadiene)rhodium (I) tetrafluoroborate, 98+%
(R,R)-Et-DUPHOS-Rh |
100mg
500mg
2g |
| 45-0149 |
(+)-1,2-Bis((2S,5S)-2,5-diethylphospholano)benzene
(cyclooctadiene)rhodium (I) tetrafluoroborate, 98+%
(S,S)-Et-DUPHOS-Rh |
100mg
500mg
2g |
45-0154 |
(+)-1,1'-Bis((2R,4R)-2,4-diethylphosphotano)ferrocene(1,5-cyclooctadiene)rhodium
(I) tetrafluoroborate, min. 98%
Note: Sold for research
purposes only. Sold in collaboration with Chirotech.
|
100mg
500mg |
45-0155 |
(-)-1,1'-Bis((2S,4S)-2,4-diethylphosphotano)ferrocene(1,5-cyclooctadiene)rhodium
(I) tetrafluoroborate, min. 98%

Note: Sold for research
purposes only. Sold in collaboration with Chirotech.
|
100mg
500mg
|
| 45-0158 |
(-)-1,2-Bis((2R,5R)-2,5-dimethylphospholano)benzene
(cyclooctadiene)rhodium (I) tetrafluoroborate, 98+%
(R,R)-Me-DUPHOS-Rh |
100mg
500mg
2g |
| 45-0159 |
(+)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)benzene
(cyclooctadiene)rhodium (I) tetrafluoroborate, 98+%
(S,S)-Me-DUPHOS-Rh |
100mg
500mg
2g |
| 45-0171 |
(+)-1,2-Bis((2R,5R)-2,5-dimethylphospholano)ethane
(cyclooctadiene)rhodium (I) trifluoromethanesulfonate,
98+%
(R,R)-Me-BPE-Rh |
100mg
500mg
2g |
| 45-0170 |
(-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane
(cyclooctadiene)rhodium (I) trifluoromethanesulfonate,
98+% (S,S)-Me-BPE-Rh
 |
100mg
500mg
2g |
45-0205 |
1,1'-Bis(di-i-propylphosphino)ferrocene
(1,5-cyclooctadiene)rhodium (I) tetrafluoroborate,
min. 98% |
250mg
1g |
RUTHENIUM |
|
44-0070 |
Bis(tricyclohexylphosphine)3-methyl-2-butenylidene
ruthenium (IV) dichloride
 |
1g
5g |
44-0080 |
Bis(tricyclopentylphosphine)3-methyl-2-butenylidene
ruthenium (IV) dichloride |
1g
5g |
44-0210 |
Dichloro[(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(2R)-(-)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine]ruthenium
(II), min. 95%
 |
10mg
50mg
250mg |
44-0211 |
Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(2S)-(+)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine]ruthenium
(II), min. 95% |
10mg
50mg
250mg |
44-0220 |
Dichloro[(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1R,2R)-(+)-1,2-diphenylethylenediamine]ruthenium
(II), min. 98%
 |
10mg
50mg
250mg |
44-0221 |
Dichloro[(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium
(II), min. 98% |
10mg
50mg
250mg |
44-0222 |
Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1R,2R)-(+)-1,2-diphenylethylenediamine]ruthenium
(II), min. 98% |
10mg
50mg
250mg |
44-0223 |
Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium
(II), min. 98% |
10mg
50mg
250mg |
| 44-0248 |
Dichloro[(R)-(+)-2,2'-bis(diphenyl-phosphino)-1,1'-
binaphthyl]ruthenium (II), min. 95% |
500mg
2g
10g |
44-7770 |
Tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene][benzylidine]ruthenium
(IV) dichloride
SECOND GENERATION GRUBBS'S CATALYST
 |
500mg
2g |
|